AEGIS PHARMA AND NUTRITION LIMITED

💤Zombieactive
12346100 · ltd · incorporated 2019-12-03
Investment thesis
Zombie company — trading but stalled; unlikely mover.
Why interesting: Quiet, steady; could be a succession or carve-out candidate with the right conversation.
Why risky: No growth signal; thin margin for error on price.
🔒Estimated value
Upgrade to see
Turnover
year to Dec 2024
Net worth
book net assets
Opportunity
76/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Other human health activities
Sector: Human health & social work
Investor take
Pursue
Strong opportunity: active trading company with strong profile and bankable structure.

Opportunity 76/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (73/100).

Data confidence

Overall: medium (69/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
1 officers (1 active, 1 linked, 1 with DOB)
90
Ownership & PSC
No PSCs filed (unusual — worth investigating)
35
Director network
Network not yet resolved
30
Filing history
16 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
76/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
65
Adequate — check latest filings for context.
Acquirability
70
Strong succession / seller-readiness signals.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Key financials

2 years extracted from filed iXBRL accounts
Cash
Net Worth
Current Assets
Current Liabilities
£0£0£0£0£0£0Dec 2023Dec 2024

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 102
Metric2024-12-312023-12-31

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

Recent activity

Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
1
filing
  • 1 confirmation-statement
Counts from Companies House filing history.
Corporate timeline (12 events)Click to expand
  1. 2025-10-01
    📄
    accounts-with-accounts-type-dormant
    accounts · AA
  2. 2024-09-29
    📄
    accounts-with-accounts-type-dormant
    accounts · AA
  3. 2023-09-30
    📄
    accounts-with-accounts-type-dormant
    accounts · AA
  4. 2022-06-14
    📄
    change-person-director-company-with-change-date
    officers · CH01
  5. 2022-06-13
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  6. 2022-02-06
    📄
    accounts-with-accounts-type-dormant
    accounts · AA
  7. 2021-12-14
    📄
    accounts-with-accounts-type-dormant
    accounts · AA
  8. 2021-12-11
    📄
    gazette-filings-brought-up-to-date
    gazette · DISS40
  9. 2021-12-07
    📄
    gazette-notice-compulsory
    gazette · GAZ1
  10. 2019-12-03
    🏢
    Company incorporated
    As AEGIS PHARMA AND NUTRITION LIMITED
  11. 2019-12-03
    AHMAD, Khalid appointed
    director
  12. 2019-12-03
    📄
    incorporation-company
    incorporation · NEWINC

Owner dependency

88/100
Critical — business is the founder

The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.

FACTORS
  • +Sole director: Only one active director — all governance concentrated on one person.
  • +Senior director age: Director aged approximately 58 — approaching natural succession window.
  • +No director turnover: Company is 7 years old with no director changes — suggests a very tight-knit founder team never broadened.

Succession & seller-readiness

55/100
Strong succession signal

Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.

SIGNALS
  • secondaryFounder aged 58+: Senior director is approximately 58. Early succession window.
  • primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Similar companies

Active · Healthcare & medical · EC postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
A&JK HOLDINGS LTD
16868724 · est 2025 · no financials extracted
AESTHETIC BIDCO LIMITED
15149317 · est 2023 · no financials extracted
2y
AGE CONCERN READING
04750114 · est 2003 · no financials extracted
22y
AGEING AND DISABILITY CARE SERVICES UK LIMITED
17075721 · est 2026 · no financials extracted
AGILE MED LTD
13977415 · est 2022 · no financials extracted
4y
AION CLINIC LTD
16034134 · est 2024 · no financials extracted
1y
AIRA ASSOCIATES LTD
16695638 · est 2025 · no financials extracted
AIRYN LTD
16455419 · est 2025 · no financials extracted
AISH OPTICAL LTD
13836734 · est 2022 · no financials extracted
4y
AISHAH HELP
11902309 · est 2019 · no financials extracted
7y
AISLING EVE RICHARDS OH SERVICES LTD
16938051 · est 2025 · no financials extracted
AIZ HAIR PROFESSIONALS LTD
14530886 · est 2022 · no financials extracted
3y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2019-12-03
Jurisdictionengland-wales
Primary SIC86900 — Other human health activities

Registered office

128 City Road
London
EC1V 2NX
United Kingdom

Filing status

Accounts
Next due: 2026-09-30
Last made up to: 2024-12-31
Confirmation statement
Next due: 2026-12-14
Last: 2025-11-30

Officers (1 active · 0 resigned)

AHMAD, Khalid
director · ~58y · appointed 2019-12-03
View their other companies + combined net worth →
Active

Click a director name to see their full track record across all companies.

Recent filings (16 total)

confirmation-statement-with-no-updates
confirmation-statement · CS01
2026-01-07
accounts-with-accounts-type-dormant
accounts · AA
2025-10-01
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-12-08
accounts-with-accounts-type-dormant
accounts · AA
2024-09-29
confirmation-statement-with-no-updates
confirmation-statement · CS01
2023-12-14
accounts-with-accounts-type-dormant
accounts · AA
2023-09-30
confirmation-statement-with-no-updates
confirmation-statement · CS01
2022-12-09
change-person-director-company-with-change-date
officers · CH01
2022-06-14
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2022-06-13
accounts-with-accounts-type-dormant
accounts · AA
2022-02-06
accounts-with-accounts-type-dormant
accounts · AA
2021-12-14
gazette-filings-brought-up-to-date
gazette · DISS40
2021-12-11
confirmation-statement-with-no-updates
confirmation-statement · CS01
2021-12-10
gazette-notice-compulsory
gazette · GAZ1
2021-12-07
confirmation-statement-with-no-updates
confirmation-statement · CS01
2020-11-30